Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients.
Weinstock
David M
DM
Boeckh
Michael
M
Sepkowitz
Kent A
KA
D000212:Acyclovir / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019433:Chickenpox Vaccine; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004781:Environmental Exposure; D018380:Hematopoietic Stem Cell Transplantation; D006562:Herpes Zoster / Q000517:prevention & control* / Q000635:transmission; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage* / Q000191:economics / Q000276:immunology; D007116:Immunization, Passive / Q000191:economics; D007223:Infant; D009316:National Institutes of Health (U.S.); D011183:Postoperative Complications / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011292:Premedication; D012680:Sensitivity and Specificity; D014481:United States; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use
D000914:Antibodies, Viral; D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D007106:Immune Sera; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir